Title : Inhibition of glucose absorption by 3-phenylpropylaminoguanidine-HCl (SaH 43-522) in laboratory animals.

Pub. Date : 1977 Oct

PMID : 596983






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SaH 43-522 differs from DBI in that when glucose active transport is studied in vitro by adding drug into the incubation fluid, DBI is active only when the drug is present in the incubation fluids on both the mucosal and serosal sides, whereas SaH 43-522 is active in inhibiting intestinal glucose active transport when the drug is present in mucosal fluid only. S-Adenosylhomocysteine diazepam binding inhibitor Rattus norvegicus
2 SaH 43-522 differs from DBI in that when glucose active transport is studied in vitro by adding drug into the incubation fluid, DBI is active only when the drug is present in the incubation fluids on both the mucosal and serosal sides, whereas SaH 43-522 is active in inhibiting intestinal glucose active transport when the drug is present in mucosal fluid only. S-Adenosylhomocysteine diazepam binding inhibitor Rattus norvegicus